Ju-Yeon Choi

5PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 04, 2026
Time-Resolved Transcriptomic Profiling of Surgical Wounds Identifies Stage-Specific Therapeutic Targets for Residual Ovarian Cancer.

|Sep 03, 2024
Anticancer effect of the antipsychotic agent penfluridol on epithelial ovarian cancer.

Won-Ji Kim, Ji-Yoon Ryu, Chi-Son Chang

|Aug 08, 2024
Evaluation of Anticancer Efficacy of D-α-Tocopheryl Polyethylene-Glycol Succinate and Soluplus® Mixed Micelles Loaded with Olaparib and Rapamycin Against Ovarian Cancer.

Yu Been Shin, Ju-Yeon Choi, Moon Sup Yoon

|May 12, 2023
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer.

Chi-Son Chang, Ji-Yoon Ryu, June-Kuk Choi

|May 08, 2023
Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles Encapsulating Fenbendazole and Rapamycin in Ovarian Cancer.

Yu Been Shin, Ju-Yeon Choi, Dae Hwan Shin

Pageof 1

Frequent Collaborators

5 joint publications

Jeong-Won Lee

2 joint publications

Chi-Son Chang

2 joint publications

Young-Jae Cho

2 joint publications

Young-Jae Cho